Search Results for: mri world

2022 was somewhat challenging for vendors of fixed digital radiography (DR) systems, with market expansion impeded by inflationary pressure, stretched healthcare budgets and increased average selling prices.

Machine learning was undoubtedly one of the hottest topics in radiology last year, with a steady stream of academic research papers highlighting how machine learning, particularly deep learning, can outperform traditional algorithms or manual processes in certain use-cases.

When breast imaging comes to mind, mammography is the undisputed current modality of choice. Used as the primary screening tool for breast cancer, other breast imaging (BI) modalities, such as MRI and ultrasound, form a comparatively smaller part of the market.

Since the pandemic, the teleradiology market has experienced re-vitalised growth amid a strained global economic recovery.  The total teleradiology market (reading services and IT revenue) grew over 21% YOY in 2022 to $2.1bn. As significant influences, such as radiologist shortages, continued reimbursement cuts, innovation, and technology adoption propel the market forward, the future seems bright. By 2027, Signify Research forecasts the total teleradiology market will hit over $4.3bn and is expected to perform over 173k reads.  

Despite declining tobacco use, lung cancer remains the leading cause of cancer deaths globally, often evading detection until advanced stages. It is unsurprising, then, that interest in targeted lung screening (LCS) programmes has risen markedly in recent decades

The ultrasound market is forecast to recover in 2023 from the supply chain and macroeconomic issues that impacted the market in 2022. The impacts of these macro-influences also impacted regional markets in varying degrees - our round up of the main geographical market changes are outlined below.

Following attendance at BioTechX in Basel, Imogen Fitt from Signify Research shares her thoughts on the current landscape for using clinical data in Real-World Evidence Studies.

The launch of NVIDIA's Cambridge-1 Supercomputer signals a bullish outlook from the firm for the future development of the AI in healthcare market. Cambridge-1's list of potential applications ranges across healthcare domains, with partnerships geared towards medical imaging, genomics and drug development.

As well as attending the ECR show in Vienna, Signify Research analysts also provided a daily column for the Congress Newspaper – ECR Today.